Quantenna to Release Second Quarter 2017 Financial Results on August 7, 2017
Jul 24, 2017 20:15 pm UTC| Business
FREMONT, Calif., July 24, 2017 -- Quantenna Communications, Inc. (NASDAQ:QTNA), a global leader and innovator of leading-edge performance Wi-Fi solutions, will release its financial results for the second quarter of...
Quanex Building Products Promotes George Wilson to Chief Operating Officer
Jul 24, 2017 20:15 pm UTC| Business
HOUSTON, TEXAS, July 24, 2017 -- Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced that it has promoted George Wilson to Chief Operating Officer, effective August 1, 2017. In...
Phibro Animal Health Corporation Declares Quarterly Dividend
Jul 24, 2017 20:15 pm UTC| Business
TEANECK, N.J., July 24, 2017 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock,...
DCP Midstream Announces Quarterly Distribution
Jul 24, 2017 20:15 pm UTC| Business
DENVER, July 24, 2017 -- DCP Midstream, LP (NYSE:DCP) announced today that the board of directors of its general partner declared a quarterly cash distribution of $0.78 per common unit for the quarter ended June 30,...
Park National Corporation reports financial results for second quarter and first half of 2017
Jul 24, 2017 20:15 pm UTC| Business
NEWARK, Ohio, July 24, 2017 -- Park National Corporation (Park) (NYSE American:PRK) today announced financial results for the second quarter and first half of 2017 (three and six months ended June 30, 2017). Park’s...
Mercury Systems Receives $8.5M High Density Secure Memory Order for Military Avionics Applications
Jul 24, 2017 20:15 pm UTC| Business
ANDOVER, Mass., July 24, 2017 -- Mercury Systems, Inc. (NASDAQ:MRCY) (www.mrcy.com) announced it received an $8.5M follow-on order from a leading defense prime contractor for high density secure memory devices for...
Jul 24, 2017 20:05 pm UTC| Business
Phase 2 data in older adults (E205) demonstrate adjuvants and 2-dose regimens significantly increase the magnitude, duration and quality of the RSV F Vaccine immune response New data demonstrate that Novavax’ construct is...